SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus: into single digits

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MIKE DUBIS who wrote (415)5/4/1998 12:00:00 PM
From: MIKE DUBIS  Read Replies (2) of 1016
 
Script numbers for PFE

NEW YORK, May 4 (Reuters) - New U.S. prescriptions for
Pfizer Inc. impotence drug Viagra leaped to 207,868 in
the week ending April 24, its third week on the market --
eclipsing its stellar performance during prior weeks,
PaineWebber analyst Jeff Chaffkin told Reuters.
Chaffkin said data obtained by him from auditing firm IMS
America showed sales of Viagra continued to grow apace, easily
outstripping the 113,134 new prescriptions written for the
first impotence pill during the prior week ending April 17.
"It's just a tremendous number," Chaffkin said of the
third-week results.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext